Cambium

• 06/12/2023
• Series A
• $19,000,000

Cambium works at the interface of biotech and materials science to build next-generation defense products. We integrate computational chemistry, product design, and advanced manufacturing methods to solve difficult challenges like hardening critical assets against laser attack, protecting payloads during hypersonic flight, and streamlining the defense product manufacturing supply chain. Our people come from places like SpaceX, Anduril, Scaled Composites, Lockheed Martin Skunkworks, and US DoD Research Labs.

---

---